Table 1.
Percentage | Frequency | Total N | ||
---|---|---|---|---|
Index event characteristics | ||||
Index event | COVID related | 24 | 25 | 103 |
COVID unrelated | 76 | 78 | 103 | |
Pre‐pandemic a | 63 | 65 | 103 | |
Post‐pandemic | 37 | 38 | 103 | |
Occupational | 52 | 54 | 103 | |
Personal | 48 | 49 | 103 | |
Rates of positive screens and diagnoses b | ||||
PTSD | PCL‐5 Positive screen | 38 | 39 | 103 |
SCID Diagnosed | 44 | 45 | 56 | |
MDD | PHQ‐9 Positive screen | 55 | 57 | 103 |
SCID Diagnosed | 39 | 40 | 56 | |
Co‐morbid PTSD MDD | PCL‐5 or PHQ‐Positive Screen | 54 | 60 | 103 |
SCID Diagnosed | 29 | 30 | 103 | |
Index event characteristics in SCID diagnosed PTSD | ||||
Index event | COVID related | 27 | 12 | 45 |
COVID unrelated | 73 | 33 | 45 | |
Pre‐pandemic | 60 | 27 | 45 | |
Post‐pandemic | 40 | 18 | 45 | |
Occupational | 56 | 25 | 45 | |
Personal | 44 | 20 | 45 | |
Onset of symptoms in individuals meeting diagnostic criteria for PTSD or MDD | ||||
SCID PTSD onset | Pre‐pandemic | 47 | 21 | 45 |
Post‐pandemic | 53 | 24 | 45 | |
Index event pre‐pandemic: Onset | Pre‐pandemic | 85 | 23 | 27 |
Post‐pandemic | 15 | 4 | 27 | |
SCID MDD onset | Pre‐pandemic | 15 | 6 | 40 |
Post‐pandemic | 85 | 34 | 40 |
PCL‐5 = PTSD Checklist for DSM‐5, PHQ‐9 = Patient Health Questionnaire, SCID = Structured Clinical Interview for DSM‐5.
Pre‐pandemic was considered to be any date prior to the WHO declaration in March 2020
Diagnostic interview administered to N = 59 above cut off on either screening measure N = 3 participants with a positive screen were uncontactable for assessment.